These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
141 related items for PubMed ID: 2553428
1. Diethyldithiocarbamate and disulfiram inhibit MPP+ and dopamine uptake by striatal synaptosomes. Di Monte D, Irwin I, Kupsch A, Cooper S, DeLanney LE, Langston JW. Eur J Pharmacol; 1989 Jul 04; 166(1):23-9. PubMed ID: 2553428 [Abstract] [Full Text] [Related]
2. 1-methyl-4-phenylpyridinium (MPP+) analogs: in vivo neurotoxicity and inhibition of striatal synaptosomal dopamine uptake. Johnson EA, Wu EY, Rollema H, Booth RG, Trevor AJ, Castagnoli N. Eur J Pharmacol; 1989 Jul 04; 166(1):65-74. PubMed ID: 2806366 [Abstract] [Full Text] [Related]
3. Inhibition of uptake of 1-methyl-4-phenylpyridinium ion and dopamine in striatal synaptosomes by tobacco smoke components. Carr LA, Basham JK, York BK, Rowell PP. Eur J Pharmacol; 1992 May 14; 215(2-3):285-7. PubMed ID: 1396992 [Abstract] [Full Text] [Related]
4. Diethyldithiocarbamate potentiates the neurotoxicity of in vivo 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and of in vitro 1-methyl-4-phenylpyridinium. Miller DB, Reinhard JF, Daniels AJ, O'Callaghan JP. J Neurochem; 1991 Aug 14; 57(2):541-9. PubMed ID: 1649252 [Abstract] [Full Text] [Related]
5. In brown Norway rats, MPP+ is accumulated in the nigrostriatal dopaminergic terminals but it is not neurotoxic: a model of natural resistance to MPTP toxicity. Zuddas A, Fascetti F, Corsini GU, Piccardi MP. Exp Neurol; 1994 May 14; 127(1):54-61. PubMed ID: 8200437 [Abstract] [Full Text] [Related]
6. 1-Methyl-4-phenylpyridinium uptake by human and rat striatal synaptosomes. Willoughby J, Cowburn RF, Hardy JA, Glover V, Sandler M. J Neurochem; 1989 Feb 14; 52(2):627-31. PubMed ID: 2783454 [Abstract] [Full Text] [Related]
7. Striatal MPP+ levels do not necessarily correlate with striatal dopamine levels after MPTP treatment in mice. Vaglini F, Fascetti F, Tedeschi D, Cavalletti M, Fornai F, Corsini GU. Neurodegeneration; 1996 Jun 14; 5(2):129-36. PubMed ID: 8819133 [Abstract] [Full Text] [Related]
8. Active uptake of MPP+, a metabolite of MPTP, by brain synaptosomes. Chiba K, Trevor AJ, Castagnoli N. Biochem Biophys Res Commun; 1985 May 16; 128(3):1228-32. PubMed ID: 3873939 [Abstract] [Full Text] [Related]
9. A new in vitro approach for investigating the MPTP effect on DA uptake. Barc S, Page G, Fauconneau B, Barrier L, Huguet F. Neurochem Int; 2001 Mar 16; 38(3):243-8. PubMed ID: 11099783 [Abstract] [Full Text] [Related]
10. Implication of dopamine transporter system on 1-methyl-4-phenylpyridinium and rotenone effect in striatal synaptosomes. Bougria M, Vitorica J, Cano J, Machado A. Eur J Pharmacol; 1995 Nov 30; 291(3):407-15. PubMed ID: 8719427 [Abstract] [Full Text] [Related]
11. Effect of ascorbic acid on the synaptosomal uptake of [3H]MPP+, [3H]dopamine, and [14C]GABA. Sershen H, Debler EA, Lajtha A. J Neurosci Res; 1987 Nov 30; 17(3):298-301. PubMed ID: 3496464 [Abstract] [Full Text] [Related]
12. Inhibition by dizocilpine (MK-801) of striatal dopamine release induced by MPTP and MPP+: possible action at the dopamine transporter. Clarke PB, Reuben M. Br J Pharmacol; 1995 Jan 30; 114(2):315-22. PubMed ID: 7881731 [Abstract] [Full Text] [Related]
13. Depletion of striatal dopamine by the N-oxide of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). Lau YS, Fung YK, Trobough KL, Cashman JR, Wilson JA. Neurotoxicology; 1991 Jan 30; 12(2):189-99. PubMed ID: 1956580 [Abstract] [Full Text] [Related]
14. Inhibition of [3H]dopamine uptake into striatal synaptosomes by isoquinoline derivatives structurally related to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. McNaught KS, Thull U, Carrupt PA, Altomare C, Cellamare S, Carotti A, Testa B, Jenner P, Marsden CD. Biochem Pharmacol; 1996 Jul 12; 52(1):29-34. PubMed ID: 8678905 [Abstract] [Full Text] [Related]
15. Disulfiram and diethyldithiocarbamate intoxication affects the storage and release of striatal dopamine. Vaccari A, Saba PL, Ruiu S, Collu M, Devoto P. Toxicol Appl Pharmacol; 1996 Jul 12; 139(1):102-8. PubMed ID: 8685891 [Abstract] [Full Text] [Related]
16. Serotonergic conversion of MPTP and dopaminergic accumulation of MPP+. Shen RS, Abell CW, Gessner W, Brossi A. FEBS Lett; 1985 Sep 23; 189(2):225-30. PubMed ID: 3876242 [Abstract] [Full Text] [Related]
17. Pharmacological properties of the MPTP analog trans-1-methyl-4-[4-dimethylaminophenylethenyl]-1,2,3,6-tetrahydropyridine and its pyridinium metabolite in mouse brain synaptosomes: a potential visual marker for substrates of MPTP-induced neurotoxicity. Klein BG, Kirby ML, Freeborn ER, Bloomquist JR. Prog Neuropsychopharmacol Biol Psychiatry; 2001 Apr 23; 25(3):591-608. PubMed ID: 11370999 [Abstract] [Full Text] [Related]
18. Dopamine-releasing action of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and 1-methyl-4-phenylpyridine (MPP+) in the neostriatum of the rat as demonstrated in vivo by the push-pull perfusion technique: dependence on sodium but not calcium ions. Sirinathsinghji DJ, Heavens RP, McBride CS. Brain Res; 1988 Mar 08; 443(1-2):101-16. PubMed ID: 3258784 [Abstract] [Full Text] [Related]
19. Kinetics of [3H]MPP+ uptake in dopaminergic neurons of mouse: regional effects of MPTP neurotoxicity. Sershen H, Mason MF, Debler EA, Lajtha A. Eur J Pharmacol; 1986 Jul 31; 126(3):337-9. PubMed ID: 3489627 [Abstract] [Full Text] [Related]
20. Carrier-mediated efflux of [3H]dopamine and [3H]1-methyl-4-phenylpyridine: effect of ascorbic acid. Debler EA, Sershen H, Hashim A, Lajtha A, Reith ME. Synapse; 1991 Feb 31; 7(2):99-105. PubMed ID: 2011830 [Abstract] [Full Text] [Related] Page: [Next] [New Search]